 Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores
Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores
Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores
Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores
Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26
GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26 
              The Board of Directors of Bal Pharma Ltd at its meeting held on August 11, 2014, has proposed to issue 13,00,000 securities, on preferential basis to certain strategic investors who have expressed their interest in investing in the Company, which is subject to the approval of the members at the ensuing Annual General Meeting of the Company.
Shares of BAL PHARMA LTD. was last trading in BSE at Rs.59.65 as compared to the previous close of Rs. 56.85. The total number of shares traded during the day was 22286 in over 114 trades.
The stock hit an intraday high of Rs. 59.65 and intraday low of 59.65. The net turnover during the day was Rs. 1329359.